FeaturedWorld

China gives approval for Sinopharm’s Covid-19 vaccine

- Advertisement -

China approved its first COVID-19 vaccine for general public use on Thursday, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter.

No detailed efficacy data of the vaccine has been publicly released but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said on Wednesday its vaccine was 79.34% effective in preventing people from developing the disease based on interim data.

READ  Saudi: 175 test positive; 156 recovered

Comments

- Advertisement -

Related Articles

Back to top button